0001679808-16-000001.txt : 20160715 0001679808-16-000001.hdr.sgml : 20160715 20160715133615 ACCESSION NUMBER: 0001679808-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160715 DATE AS OF CHANGE: 20160715 EFFECTIVENESS DATE: 20160715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Helocyte, Inc. CENTRAL INDEX KEY: 0001679808 IRS NUMBER: 473928167 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-267116 FILM NUMBER: 161769356 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 212-554-4520 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 D 1 primary_doc.xml X0707 D LIVE 0001679808 Helocyte, Inc. 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY NEW YORK 10014 212-554-4520 DELAWARE DiaVax Biosciences, Inc. None Corporation true 2015 Frank Taffy c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Executive Officer Director Lindsay A. Rosenwald c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director Kenneth W. Cappell c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director Michael S. Weiss c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director David J. Horin c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Executive Officer Elizabeth Clark Moore c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Executive Officer Biotechnology Decline to Disclose 06b false 2016-06-30 false true false 0 Aegis Capital Corp. 15007 Aegis Capital Corp. 15007 810 Seventh Avenue 18th Floor New York NY NEW YORK 10019 All States false 5000000 1000000 4000000 false 11 100000 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false Helocyte, Inc. /s/ Frank Taffy Frank Taffy President and CEO 2016-07-15